Cyramza-500 (Ramucirumab Vials) 500mg/50ml

CYRAMZA 500mg/50ml vials contain ramucirumab, a VEGF inhibitor used in oncology. This prescription therapy is supplied as 1 single-dose vial for intravenous infusion. Store between 2-8°C to maintain stability.

Strength

500mg/50ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

ELI LILLY (SUISSE) SA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ramucirumab is used to treat certain types of cancer by slowing tumor growth. It may be prescribed for advanced gastric cancer, colorectal cancer, or non-small cell lung cancer. Patients often ask what ramucirumab is used for in combination with other therapies. This medication targets blood vessel formation supporting tumor progression.

Side Effects

Ramucirumab works by blocking signals that help tumors develop new blood vessels. Patients may notice reduced disease progression over time. Some experience infusion-related reactions during administration. Individual responses vary based on treatment protocols and cancer type.

Precautions & Warnings

Keep vials refrigerated between 2-8°C and protect from light. Avoid freezing. Handle with care using aseptic technique during preparation. Discard any unused portion as it contains no preservative. Always follow healthcare provider instructions for safe handling and disposal.

Avoid Interactions

Ramucirumab may interact with other medications affecting blood pressure or blood clotting. Patients should inform providers about all current medications before starting treatment. Certain chemotherapy drugs may be used concurrently, but specific combinations require medical supervision. Alcohol consumption should be discussed with a healthcare professional.

References

Frequently Asked Questions

Ramucirumab is used to treat certain advanced cancers by slowing tumor growth through blood vessel inhibition.

This medication is given as an intravenous infusion by healthcare professionals in a clinical setting.

Possible effects include infusion reactions, fatigue, or high blood pressure, which should be reported to a doctor.

This prescription medication requires a valid prescription and cannot be purchased without medical authorization.

Store vials refrigerated between 2-8°C and protect from light until time of use.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.